The Column Group II, LP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:14 pm Sale | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | The Column Group II, LP | 3,644,118 5.200% | -27,404 (-0.75%) | Filing |
| 2022-02-11 4:54 pm Sale | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | The Column Group II, LP | 3,671,522 9.300% | -1,096,659 (-23.00%) | Filing |
| 2021-02-12 6:24 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | The Column Group II, LP | 4,768,181 13.100% | 4,768,181 (New Position) | Filing |